Navigation Links
Medicinal chemist wins inaugural De Burgh Fellowship
Date:11/11/2010

Medicinal chemist Dr Guillaume Lessene has been awarded the Walter and Eliza Hall Institute's inaugural de Burgh Fellowship at the institute's annual general meeting in Melbourne, Australia.

The $AUD150,000 de Burgh Fellowship honours the role Professor Patrick de Burgh played in shaping the Walter and Eliza Hall Institute. It was established this year following the death of Professor de Burgh in August at the age of 94.

It was in Professor de Burgh's laboratory at the University of Sydney that institute legends Professor Donald Metcalf, Professor Jacques Miller and Sir Gustav Nossal obtained their first taste of research.

Professor de Burgh was a Bosch Professor or Bacteriology at the University of Sydney and worked on the pathogenesis of infectious disease.

Dr Lessene said it was a great honour to be named the de Burgh Fellow. "The fact the fellowship acknowledges translational research is really important that is what I do every day and it's great that these activities are supported by the fellowship and the institute," Dr Lessene said.

Dr Lessene translates research findings from the institute into the discovery and development of new drugs. His main focus is cancer research and Dr Lessene is currently working on developing inhibitors to the pro-survival Bcl-2 proteins that are involved in programmed cell death, for treatment of several types of cancer. He is also involved in projects looking at other cancer targets, such as tyrosine kinases, and non-cancer targets involved in conditions such as Alzheimer's disease.

"We work in multidisciplinary teams in constant interaction with biologists to create small molecules that will interact with or modulate recognised cell signaling pathways or targets involved in disease, with the aim of treating or curing that disease," Dr Lessene said.

"The very high standing of the research at the institute is a key element in the success of our program. The Chemical Biology division of which I am part is there to take the next step, bringing these biological discoveries from the laboratory and translating them into molecules that have the right biological activities and properties to reach clinical trials and potentially become a new drug."

Institute director Professor Doug Hilton congratulated Dr Lessene and said the institute and the Australian community owed Professor de Burgh a great debt.

"One could only imagine the shape of Australian medical research today had Professor de Burgh provided a humdrum rather than an inspiring environment," Professor Hilton said.

"The De Burgh Fellowship is awarded to a scientist with an outstanding record of research or research translation, who collaborates productively with other members of the faculty, and who is likely to make a major contribution to the institute in the long term. Guillaume meets all these criteria with aplomb."


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. Medicinal cannabis review highlights dilemmas facing health care professionals
2. Pfizer joins open-access medicinal chemistry public-private collaboration
3. St. Johns wort collection mined for its medicinal value
4. MIT chemists engineer plants to produce new drugs
5. 2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar
6. Biochemist studies DNA repair with $787,000 in grants
7. MIT moves toward greener chemistry
8. Basque researchers apply chemistry to restoration of paintings and dating of signatures
9. Subtyping breast cancer by immunohistochemistry to investigate survival terms
10. Tastier MRE: Chemistry gives battlefield chow a gourmet flare
11. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medicinal chemist wins inaugural De Burgh Fellowship
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
Breaking Medicine Technology: